SEARCH

SEARCH BY CITATION

References

  • Armstrong, S. & Lees, P. (2002) Effects of carprofen (R and S enantiomers and racemate) on the production of IL-1, IL-6 and TNF-alpha by equine chondrocytes and synoviocytes. Journal of Veterinary Pharmacology and Therapeutics, 25, 145153.
  • Blain, H., Boileau, C., Lapicque, F., Nedelec, E., Loeuille, D., Guillaume, C., Gaucher, A., Jeandel, C., Netter, P. & Jouzeau, J.Y. (2002) Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. British Journal of Clinical Pharmacology, 53, 255265.
  • Botting, R.M. (2000) Paracetamol-inhibitable COX-2. Journal of Physiological Pharmacology, 52, 609618.
  • Brideau, C., Kargman, S., Liu, S., Dallob, A.L., Ehrich, E.W., Rodget, I.W. & Chan, C.C. (1996) A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflammation Research, 45, 6874.
  • Capone, M.L., Tacconelli, S., Sciulli, M.G. & Patrignani, P. (2003) Clinical pharmacology of selective COX-2 inhibitors. International Journal of Immunopathology and Pharmacology, 16, 4958.
  • Chen, X.H., Bai, J.Y., Shen, F., Bai, A.P., Guo, Z.R. & Cheng, G.F. (2004) Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. Acta Pharmacologica Sin, 25, 927931.
  • Coruzzi, G., Menozzi, A. & Dobrilla, G. (2004) Novel non-steroidal anti-inflammatory drugs: what we have learned from animal studies. Current Drug Targets in Inflammation and Allergy, 3, 4361.
  • Cryer, B. & Feldman, M. (1998) Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. American Journal of Medicine, 104, 413421.
  • Dallob, A., Hawkey, C.J., Greenbergh, H., Wight, N., De Schepper, P., Waldman, S., Wong, P., DeTora, L., Gertz, B., Agrawal, N., Wagner, J. & Cottesdiener, K. (2003) Characterization of etoricoxib, a novel, selective COX-2 inhibitor. Journal of Clinical Pharmacology, 43, 573585.
  • Demasi, M., Caughey, G.E., James, M.J. & Celeland, L.G. (2000) Assay of cyclooxygenase-1 and 2 in human monocytes. Inflammation Research, 49, 737743.
  • Dieter, P., Scheibe, R., Jakobsson, P.J., Watanabe, K., Kolada, A. & Kamionka, S. (2000) Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages. Biochemical and Biophysical Research Communications, 276 488492.
  • Duffy, T., Belton, O., Bresnihan, B., Fitzgerald, O. & Fitzgerald, D. (2003) Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis. Drug, 63 (Suppl. 1), 3136.
  • Gilroy, D.W., Lawrence, T., Perretti, M. & Rossi, A.G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nature Reviews, Drugs Discovery, 3, 401416.
  • Giraudel, J.M., Toutain, P.L. & Lees, P. (2005) Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and predicting selectivity of nonsteroidal anti-inflammatory drugs in cats. American Journal of Veterinary Research, 66, 700709.
  • Giraudel, J.M., King, J.N., Jeunesse, E.C., Lees, P. & Toutain, P.L. (2009) Use of a pharmacokinetic/pharmacodynamic approach in the cat to the determination of a dosage regimen for the COX-2 selective drug robenacoxib. Journal of Veterinary Pharmacology and Therapeutics, 32, 1830.
  • Giuliano, F. & Warner, T.D. (1999) Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. British Journal of Pharmacology, 126, 18241830.
  • Giuliano, F. & Warner, T.D. (2002) Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human rat systems. Journal of Pharmacology and Experimental Therapeutics, 303, 10011006.
  • Giuliano, F., Ferraz, J.G., Pereira, R., De Nucci, G. & Warner, T.D. (2001) Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation. European Journal of Pharmacology, 426, 95103.
  • Griswold, D.E. & Adams, J.L. (1996) Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Medicine Research Reviews, 16, 181206.
  • Higgins, A.J. & Lees, P. (1984) Arachidonic acid metabolites in carrageenin-induced equine inflammatory exudate. Journal of Veterinary Pharmacology and Therapeutics, 7, 6572.
  • Jung, M., Lees, P., Seewald, W. & King, J.N. (2009) Analytical determination and pharmacokinetics of robenacoxib in the dog. Journal of Veterinary Pharmacology and Therapeutics, 32, 4148.
  • King, J.N., Dawson, J., Esser, R.E., Fujimoto, R., Kimble, E.F., Manara, W., Marshall, P.J., O’Bryrne, L.O., Quadros, E., Toutain, P.L. & Lees, P. (2009) Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooygenase-2. Journal of Veterinary Pharmacology and Therapeutics, 32, 117.
  • Kujubu, D.A., Fletcher, B.S., Varnum, B.C., Lim, R.W. & Herschman, H.R. (1991) TIS 10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. Journal of Biological Chemistry, 266, 1286612872.
  • Landoni, M.F., Cunningham, F.M. & Lees, P. (1995) Comparative pharmacodynamics of flunixin, ketoprofen and tolfenamic acid in calves. Veterinary Record, 137, 428431.
  • Landoni, M.F., Comas, W., Mucci, N., Anglarilli, G., Bidal, D. & Lees, P. (1999) Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep. Journal of Veterinary Pharmacology and Therapeutics, 22, 349359.
  • Laneuville, O., Breuer, D.K., Dewitt, D.L., Hla, T., Funk, C.D. & Smith, W.L. (1994) Differential inhibition of human prostaglandin endoperoxide H synthases-1 and 2 by nonsteroidal anti-inflammatory drugs. Journal of Pharmacology and Experimental Therapeutics, 271, 927934.
  • Lees, P. (2003) Pharmacology of drugs used to treat osteoarthritis in veterinary practice. Inflammopharmacology, 11, 385399.
  • Lora, M., Denault, J.B., Leduc, R. & De Brum-Fernandes, A.J. (1998) Systematic pharmacological approach to the characterization of NSAIDs. Prostaglandins Leukotrienes and Essential Fatty Acids, 59, 5562.
  • Matsumoto, H., Naraba, H., Murakami, M., Kudo, I., Yamaki, K., Ueno, A. & Oh-Ishi, S. (1997) Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production or prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rate peritoneal macrophages. Biochemical and Biophysical Research Communications, 230, 110114.
  • Mukherjee, A., Hale, V.G., Borga, O. & Stein, R. (1996) Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats. Inflammation Research, 45, 531540.
  • Pairet, M. & Van Ryn, J. (1998) Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs. Inflammation Research, 47 (Suppl 2), S93S101.
  • Panara, M.R., Padovano, R., Sciulli, M.G., Santini, G., Renda, G., Rotondo, M.T., Pace, A., Patrono, C. & Patrignani, P. (1998) Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings. Clinical Pharmacology and Therapeutics, 63, 672681.
  • Panara, M.R., Renda, G., Sciulli, M.G., Santini, G., Di Giamberardino, M., Rotondo, M.T., Tacconelli, S., Seta, F., Patrono, C. & Patrignani, P. (1999) Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. Journal of Pharmacology and Experimental Therapeutics, 290, 276280.
  • Patrignani, P., Panara, M.R., Greco, A., Fucso, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Creminon, C. & Macloud, J. (1994) Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. Journal of Pharmacology and Experimental Therapeutics, 271, 17051712.
  • Patrignani, P., Panara, M.R., Sciulli, M.G., Santini, G., Renda, G. & Patrono, C. (1997) Differential inhibition of human prostanglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. Journal of Physiological Pharmacology, 48, 623631.
  • Riendeau, D., Percival, M.D., Brideau, C., Charleson, S., Dube, D., Ethier, D., Falgueyret, J.P., Friesen, R.W., Gordon, R., Greig, G., Guay, J., Mancini, J., Quellet, M., Wong, E., Xu, L., Boyce, S., Visco, D., Girard, Y., Prasit, P., Zamboni, R., Rodget, I.W., Gresser, M., Ford-Hutchinson, A.W., Young, R.N. & Chan, C.C. (2001) Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. Journal of Pharmacology and Experimental Therapeutics, 296, 558566.
  • Simmons, D.L., Botting, R.M., Robertson, P.M., Madsen, M.L. & Vane, J.R. (1999) Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroidal anti-inflammatory drugs. Proceedings of the National Academy of Sciences, 96, 32753280.
  • Straus, D.S., Pascual, G., Li, M., Welch, J.S., Ricote, M., Hsiagn, C.-H., Senchanthalangsy, L.L., Ghosh, G. & Glass, C.K. (2000) 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-kB signalling pathway. Proceedings of the National Academy of Sciences, 97, 48444849.
  • Swinney, D.C., Mak, A.Y., Barnett, J. & Ramesha, C.S. (1997) Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid. Journal of Biological Chemistry, 272, 1239312398.
  • Taylor, P.M., Delatour, P., Landoni, F.M., Deal, C., Pickett, C., Shojaee AliAbadi, F., Foot, R. & Lees, P. (1996) Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. Research in Veterinary Science, 60, 144151.
  • Torres-Lopez, J.E., Robles, M.B., Perez-Urizar, J., Flores-Murrieta, F.J. & Granados-Soto, V. (1997) Determination of declofenac in micro-whole blood samples of high-performance liquid chromatography with electrochemical detection. Application in a pharmacokinetic study. Arzneimittel-Forschung, 47, 10401043.
  • Toutain, P.L., Cester, C.C., Haak, T. & Metge, S. (2001) Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog. Journal of Veterinary Pharmacology and Therapeutics, 24, 3542.
  • Walker, M.C., Kurumbail, R.G., Kiefer, J.R., Moreland, K.T., Koboldt, C.M., Isakson, P.C., Seibert, K. & Gierse, J.K. (2001) A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. Biochemical Journal, 357, 709718.
  • Wallace, J.L. (1999) Selective COX-2 inhibitors: is the water becoming muddy? Trends in Pharmacological Sciences, 20, 46.
  • Waver, M.L., Flood, D.J., Kimble, E.F. & Fukimoto, R.A. (2003) Lumiracoxib demonstrates preferential distribution to inflamed tissue in the rat following a single oral dose: an effect not seen with other cyclo-oxygenase-2 inhibitors. Annals of Rheumatic Diseases, 62 (Suppl 2), 538.
  • Wearner, T.D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J.A. & Vane, J.R. (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings of the National Academy of Sciences, 96, 75637568.